Rigel Pharmaceuticals RIGL Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's software and technology licenses, net?
- Rigel Pharmaceuticals (RIGL) reported software and technology licenses, net of $2.36M in Q1 2026.
- How has Rigel Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Rigel Pharmaceuticals's software and technology licenses, net increased by 55.5% year-over-year, from $1.52M to $2.36M.
- What is the long-term trend for Rigel Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's software and technology licenses, net has grown at a 18.3% compound annual growth rate (CAGR), from $824K to $1.91M.